7-120989625-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024913.5(CPED1):c.4G>A(p.Val2Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000799 in 1,613,818 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024913.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251214Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135750
GnomAD4 exome AF: 0.0000848 AC: 124AN: 1461842Hom.: 1 Cov.: 31 AF XY: 0.0000921 AC XY: 67AN XY: 727218
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74222
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2024 | The c.4G>A (p.V2I) alteration is located in exon 2 (coding exon 1) of the CPED1 gene. This alteration results from a G to A substitution at nucleotide position 4, causing the valine (V) at amino acid position 2 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at